Wounds Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

All the vital news, analysis, and commentary curated by our industry experts.

$2000

Buy Report

Published: November 30, 2022 Report Code: GDGMDHC22413IDB-ST

Report Overview
Key Players
Table of Contents
Table
Figures
FAQs

A wound is a breakdown in the protective function of the skin (the loss of continuity of epithelium) with or without loss of underlying connective tissue (i.e. muscle, bone, nerves) following injury to the skin or underlying tissues/ organs caused by surgery, a blow, a cut, chemicals, heat/ cold, friction/ shear force, pressure or as a result of diseases, such as leg ulcers or carcinomas.

The Wounds pipeline drugs market research report provides comprehensive information on the therapeutics under development for Wounds, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report offers an overview of key players involved in therapeutic development for Wounds and features dormant and discontinued projects.

Wounds Pipeline Drugs Market Segmentation by Targets

Some of the targets of the Wounds pipeline drugs market are CXXC Type Zinc Finger Protein 5, Cannabinoid Receptor 1, Cannabinoid Receptor 2, Egl Nine Homolog 1, Fibroblast Growth Factor Receptor 2, Integrin Alpha V, and Integrin Beta 3 among others. CXXC Type Zinc Finger Protein 5 leads this segment of the Wounds pipeline drugs market.

Wounds Pipeline Drugs Market Analysis, by Targets

For more Wounds pipeline drugs market target insights, download a free report sample

Wounds Pipeline Drugs Market Segmentation by Mechanisms of Action

Some of the key mechanisms of action of the Wounds pipeline drugs market are CXXC Type Zinc Finger Protein 5 Inhibitor, Cannabinoid Receptor 1 Agonist, Cannabinoid Receptor 2 Agonist, Egl Nine Homolog 1 Inhibitor, Fibroblast Growth Factor Receptor 2 Agonist, and Putative Fidgetin Like Protein 2 Inhibitor among others. CXXC Type Zinc Finger Protein 5 Inhibitor leads the Wounds pipeline drugs market in terms of MoA.

Wounds Pipeline Drugs Market Analysis, by Mechanisms of Action

For more mechanisms of action insights into the Wounds pipeline drugs market, download a free report sample

Wounds Pipeline Drugs Market Segmentation by Routes of Administration

The key routes of administration in the Wounds pipeline drugs market are Topical, Oral, Intravenous, Parenteral, Intradermal, Subcutaneous, Inhalational, Transdermal, Cutaneous, Intraarticular, Intramuscular, Intratumor, Intravenous Bolus, Nasal, Ophthalmic, and Vaginal. Topical leads the Wounds pipeline drugs market in terms of RoA.

Wounds Pipeline Drugs Market Analysis, by Routes of Administration

For more routes of administration insights into the Wounds pipeline drugs market, download a free report sample

Wounds Pipeline Drugs Market Segmentation by Molecule Types

The molecule types in the Wounds pipeline drugs market are Small Molecule, Recombinant Protein, Biologic, Cell Therapy, Synthetic Peptide, Gene Therapy, Peptide, Protein, Fusion Protein, Enzyme, Recombinant Peptide, Antisense RNAi Oligonucleotide, Antisense Oligonucleotide, Blood Derivative, Gene-Modified Cell Therapy, Monoclonal Antibody, Oligonucleotide, Polymer, Polysaccharide, Recombinant Enzyme, and RNAi Gene Therapy. Small Molecule leads the Wounds pipeline drugs market in terms of molecule types.

Wounds Pipeline Drugs Market Analysis, by Molecule Types

For more molecule type insights into the Wounds pipeline drugs market, download a free report sample

Wounds Pipeline Drugs Market - Competitive Landscape

Some of the key companies in the Wounds pipeline drugs market are CK Regeon Inc, Aposcience AG, Cannabis Science Inc, Dominion Minerals Ltd, Eluciderm Inc, Imagine Pharma LLC, MediaPharma SRL, Valitor Inc, Aceragen Inc, Adial Pharmaceuticals Inc, and AdiSave Inc among others. CK Regeon Inc has the highest number of products under development.

Wounds Pipeline Drugs Market Analysis, by Companies

To know more about the Wounds pipeline drugs companies, download a free report sample

Wounds Pipeline Drugs Market Report Overview

Key Targets	CXXC Type Zinc Finger Protein 5, Cannabinoid Receptor 1, Cannabinoid Receptor 2, Egl Nine Homolog 1, Fibroblast Growth Factor Receptor 2, Integrin Alpha V, and Integrin Beta 3 among others
Key Mechanisms of Action	CXXC Type Zinc Finger Protein 5 Inhibitor, Cannabinoid Receptor 1 Agonist, Cannabinoid Receptor 2 Agonist, Egl Nine Homolog 1 Inhibitor, Fibroblast Growth Factor Receptor 2 Agonist, and Putative Fidgetin Like Protein 2 Inhibitor among others
Key Routes of Administration	Topical, Oral, Intravenous, Parenteral, Intradermal, Subcutaneous, Inhalational, Transdermal, Cutaneous, Intraarticular, Intramuscular, Intratumor, Intravenous Bolus, Nasal, Ophthalmic, and Vaginal
Key Molecule Types	Small Molecule, Recombinant Protein, Biologic, Cell Therapy, Synthetic Peptide, Gene Therapy, Peptide, Protein, Fusion Protein, Enzyme, Recombinant Peptide, Antisense RNAi Oligonucleotide, Antisense Oligonucleotide, Blood Derivative, Gene-Modified Cell Therapy, Monoclonal Antibody, Oligonucleotide, Polymer, Polysaccharide, Recombinant Enzyme, and RNAi Gene Therapy
Key Companies	CK Regeon Inc, Aposcience AG, Cannabis Science Inc, Dominion Minerals Ltd, Eluciderm Inc, Imagine Pharma LLC, MediaPharma SRL, Valitor Inc, Aceragen Inc, Adial Pharmaceuticals Inc, and AdiSave Inc among others

Scope

The pipeline guide provides a snapshot of the global therapeutic landscape of Wounds.
The pipeline guide reviews pipeline therapeutics for Wounds by companies and universities/research institutes based on information derived from company and industry-specific sources.
The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration to discovery and undisclosed stages.
The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
The pipeline guide reviews key companies involved in Wounds therapeutics and enlists all their major and minor projects.
The pipeline guide evaluates Wounds therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA), and molecule type.
The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
The pipeline guide reviews the latest news related to pipeline therapeutics for Wounds

Reasons to Buy

Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

Recognize emerging players with a potentially strong product portfolio and create effective counterstrategies to gain a competitive advantage.

Find and recognize significant and varied types of therapeutics under development for Wounds.

Classify potential new clients or partners in the target demographic.

Develop tactical initiatives by understanding the focus areas of leading companies.

Plan mergers and acquisitions meritoriously by identifying key players and their most promising pipeline therapeutics.

Formulate corrective measures for pipeline projects by understanding the Wounds pipeline depth and focus of Indication therapeutics.

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

Adjust the therapeutic portfolio by recognizing discontinued projects and understanding from the know-how what drove them from the pipeline.

Aceragen Inc
Adial Pharmaceuticals Inc
AdiSave Inc
Agile Sciences Inc
AiViva BioPharma Inc
Akthelia Pharmaceuticals Ltd
AlgiPharma AS
Allander Biotechnologies LLC
Alliance Pharma Plc
American CryoStem Corp
AMNICELL Corp Ltd
Amniotics AB
Ankasa Regenerative Therapeutics Inc
Aposcience AG
Araim Pharmaceuticals Inc
Auxagen Inc
Axolo Pharma Inc
Bacainn Therapeutics Inc
Biomendics LLC
BioNTech SE
Bioxytran Inc
Bopin (Shanghai) Biomedical Technology Co Ltd
Cannabis Science Inc
Canton Biotechnologies Inc
Cartesian Therapeutics Inc
Causeway Therapeutics Ltd
Cellphire Inc
CK Regeon Inc
Clene Inc
Coegin Pharma AS
Connext Co Ltd
Crioestaminal Saude e Tecnologia SA
Curexsys GmbH
Daewoong Pharmaceutical Co Ltd
Destiny Pharma Plc
Dominion Minerals Ltd
Dong-A Socio Holdings Co Ltd
Eluciderm Inc
Exogenus Therapeutics SA
Exopharm Ltd
EyeGene Inc
FortuneRock (China) Ltd
Gene Signal International SA
Helixmith Co Ltd
Ilya Pharma AB
Imagine Pharma LLC
Issar Pharmaceuticals Pvt Ltd
Jiangsu ProteLight Pharmaceutical & Biotechnology Co Ltd
Juventas Therapeutics Inc
Krystal Biotech Inc
LayerBio Inc
Lutris Pharma
Madam Therapeutics BV
MangoGen Pharma Inc
Marizyme Inc
MediaPharma SRL
MediWound Ltd
MicroCures Inc
Mithra Pharmaceuticals SA
NellOne Therapeutics Inc
NextPhase Therapeutics
Novopyxis Inc
Omeros Corp
Ondine Biomedical Inc
Opal Biosciences Ltd
Orgenesis Inc
Pacific Northwest Biotechnology LLC
Panorama Researchama Research
Phoenicia Biosciences Inc
PrimeGen Global Inc
RadBio
Regeneus Ltd
Reponex Pharmaceuticals AS
Resolys Bio Inc
Reven Holdings Inc
Revive Therapeutics Ltd
RION Health Inc
Riptide Bioscience Inc
Scarless Laboratories Inc
SERDA Therapeutics BV
SomaGenics Inc
Surrozen Inc
Tego Science Inc
TGV-Inhalonix Inc
Thesan Pharmaceuticals Inc
Topadur Pharma AG
Transwell Biotech Co Ltd
Traverse Biosciences Inc
Tumorend LLC
Unicocell Biomed Co Ltd
Valitor Inc
Vascular BioSciences
VascVersa Ltd
Vasomune Inc
viDA Therapeutics Inc
Viridian Therapeutics Inc
Vitti Labs LLC
Wuhan Healthgen Biotechnology Corp
Yabao Pharmaceutical Group Co Ltd
Zih Yuan Tang Biotechnology Co Ltd
ZZ Biotech LLC

Table of Contents

List of Tables

List of Figures

Introduction

Global Markets Direct Report Coverage

Wounds – Overview

Wounds – Therapeutics Development

Pipeline Overview

Pipeline by Companies

Pipeline by Universities/Institutes

Products under Development by Companies

Products under Development by Universities/Institutes

Wounds – Therapeutics Assessment

Assessment by Target

Assessment by Mechanism of Action

Assessment by Route of Administration

Assessment by Molecule Type

Wounds – Companies Involved in Therapeutics Development

Wounds – Drug Profiles

Wounds – Dormant Projects

Wounds – Discontinued Products

Wounds – Product Development Milestones

Table

List of Tables

Number of Products under Development for Wounds, 2022

Number of Products under Development by Companies, 2022

Number of Products under Development by Universities/Institutes, 2022

Products under Development by Companies, 2022

Products under Development by Universities/Institutes, 2022

Number of Products by Stage and Target, 2022

Number of Products by Stage and Mechanism of Action, 2022

Number of Products by Stage and Route of Administration, 2022

Number of Products by Stage and Molecule Type, 2022

Wounds – Dormant Projects, 2022

Wounds – Discontinued Products, 2022

Figures

List of Figures

Number of Products under Development for Wounds, 2022

Number of Products under Development by Companies, 2022

Number of Products under Development by Universities/Institutes, 2022

Number of Products by Top 10 Targets, 2022

Number of Products by Stage and Top 10 Targets, 2022

Number of Products by Top 10 Mechanism of Actions, 2022

Number of Products by Stage and Top 10 Mechanism of Actions, 2022

Number of Products by Top 10 Routes of Administration, 2022

Number of Products by Stage and Top 10 Routes of Administration, 2022

Number of Products by Top 10 Molecule Types, 2022

Number of Products by Stage and Top 10 Molecule Types, 2022

Frequently asked questions

What are the key targets of the Wounds pipeline drugs market?

Some of the targets of the Wounds pipeline drugs market are CXXC Type Zinc Finger Protein 5, Cannabinoid Receptor 1, Cannabinoid Receptor 2, Egl Nine Homolog 1, Fibroblast Growth Factor Receptor 2, Integrin Alpha V, and Integrin Beta 3 among others.
What are the key mechanisms of action in the Wounds pipeline drugs market?

Some of the mechanisms of action of the Wounds pipeline drugs market are CXXC Type Zinc Finger Protein 5 Inhibitor, Cannabinoid Receptor 1 Agonist, Cannabinoid Receptor 2 Agonist, Egl Nine Homolog 1 Inhibitor, Fibroblast Growth Factor Receptor 2 Agonist, and Putative Fidgetin Like Protein 2 Inhibitor among others.
What are the key routes of administration in the Wounds pipeline drugs market?

The key routes of administration in the Wounds pipeline drugs market are Topical, Oral, Intravenous, Parenteral, Intradermal, Subcutaneous, Inhalational, Transdermal, Cutaneous, Intraarticular, Intramuscular, Intratumor, Intravenous Bolus, Nasal, Ophthalmic, and Vaginal.
What are the key molecule types in the Wounds pipeline drugs market?

The molecule types in the Wounds pipeline drugs market are Small Molecule, Recombinant Protein, Biologic, Cell Therapy, Synthetic Peptide, Gene Therapy, Peptide, Protein, Fusion Protein, Enzyme, Recombinant Peptide, Antisense RNAi Oligonucleotide, Antisense Oligonucleotide, Blood Derivative, Gene-Modified Cell Therapy, Monoclonal Antibody, Oligonucleotide, Polymer, Polysaccharide, Recombinant Enzyme, and RNAi Gene Therapy.
Which are the leading companies in the Wounds pipeline drugs market?

Some of the leading companies in the Wounds pipeline drugs market are CK Regeon Inc, Aposcience AG, Cannabis Science Inc, Dominion Minerals Ltd, Eluciderm Inc, Imagine Pharma LLC, MediaPharma SRL, Valitor Inc, Aceragen Inc, Adial Pharmaceuticals Inc, and AdiSave Inc among others.

Wounds Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update standard reports

Currency USD

Single User

$2,000

Can be used by individual purchaser only

Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise. The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS

Related reports

View more Dermatology reports

Pharmaceuticals

New

New Drug Approvals and Their Contract Manufacture - 2024 Edition

Pharmaceuticals

New

Methicillin-Resistant Staphylococcus aureus (MRSA) Epidemiology Analysis and Forecast to 2033

Pharmaceuticals

New

Antibody-Drug Conjugates (ADC) Overview, Industry Trends, Marketed and Pipeline Products,…

Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Wounds Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update in real time.

Access a live Wounds Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update dashboard for 12 months, with up-to-the-minute insights.
Fuel your decision making with real-time deal coverage and media activity.
Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.

Tell me more

Reports

Reports by Sector

Report Type

Wounds Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Wounds Pipeline Drugs Market Segmentation by Targets

Wounds Pipeline Drugs Market Segmentation by Mechanisms of Action

Wounds Pipeline Drugs Market Segmentation by Routes of Administration

Wounds Pipeline Drugs Market Segmentation by Molecule Types

Wounds Pipeline Drugs Market - Competitive Landscape

Wounds Pipeline Drugs Market Report Overview

Reasons to Buy

Table of Contents

Table

Figures

Frequently asked questions

Undecided about purchasing this report?

Get in touch to find out about multi-purchase discounts

Related reports